Number of items: 4.
2022
Ziemssen, Tjalf,
Richter, Stephan,
Mäurer, Mathias,
Buttmann, Mathias,
Kreusel, Boris,
Poehler, Anne-Maria,
Lampl, Maren and
Linker, Ralf A.
(2022)
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany.
Frontiers in Neurology 13.
Fulltext not available.
2021
Wiendl, Heinz,
Gold, Ralf,
Berger, Thomas,
Derfuss, Tobias,
Linker, Ralf A.,
Mäurer, Mathias,
Stangel, Martin,
Aktas, Orhan,
Baum, Karl,
Berghoff, Martin,
Bittner, Stefan,
Chan, Andrew,
Czaplinski, Adam,
Deisenhammer, Florian,
Di Pauli, Franziska,
Du Pasquier, Renaud,
Enzinger, Christian,
Fertl, Elisabeth,
Gass, Achim,
Gehring, Klaus,
Gobbi, Claudio,
Goebels, Norbert,
Guger, Michael,
Haghikia, Aiden,
Hartung, Hans‑Peter,
Heidenreich, Fedor,
Hoffmann, Olaf,
Hunter, Zoë R.,
Kallmann, Boris,
Kleinschnitz, Christoph,
Klotz, Luisa,
Leussink, Verena,
Leutmezer, Fritz,
Limmroth, Volker,
Lünemann, Jan D.,
Lutterotti, Andreas,
Meuth, Sven G.,
Meyding-Lamadé, Uta,
Platten, Michael,
Rieckmann, Peter,
Schmidt, Stephan,
Tumani, Hayrettin,
Weber, Martin S.,
Weber, Frank,
Zettl, Uwe K.,
Ziemssen, Tjalf and
Zipp, Frauke
(2021)
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper).
Der Nervenarzt 92 (8), pp. 773-801.
Wiendl, Heinz,
Gold, Ralf,
Berger, Thomas,
Derfuss, Tobias,
Linker, Ralf ,
Mäurer, Mathias,
Aktas, Orhan,
Baum, Karl,
Berghoff, Martin,
Bittner, Stefan,
Chan, Andrew,
Czaplinski, Adam,
Deisenhammer, Florian,
Di Pauli, Franziska,
Du Pasquier, Renaud,
Enzinger, Christian,
Fertl, Elisabeth,
Gass, Achim,
Gehring, Klaus,
Gobbi, Claudio,
Goebels, Norbert,
Guger, Michael,
Haghikia, Aiden,
Hartung, Hans-Peter,
Heidenreich, Fedor,
Hoffmann, Olaf,
Kallmann, Boris,
Kleinschnitz, Christoph ,
Klotz, Luisa,
Leussink, Verena I.,
Leutmezer, Fritz,
Limmroth, Volker,
Lünemann, Jan D.,
Lutterotti, Andreas,
Meuth, Sven G.,
Meyding-Lamadé, Uta,
Platten, Michael,
Rieckmann, Peter,
Schmidt, Stephan,
Tumani, Hayrettin,
Weber, Frank,
Weber, Martin S.,
Zettl, Uwe K.,
Ziemssen, Tjalf and
Zipp, Frauke
(2021)
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Therapeutic Advances in Neurological Disorders 14, p. 175628642110396.
Fulltext not available.
2019
Mäurer, Mathias,
Tiel-Wilck, Klaus,
Oehm, Eckard,
Richter, Nils,
Springer, Michael,
Oschmann, Patrick,
Manzel, Arndt,
Hieke-Schulz, Stefanie,
Zingler, Vera,
Kandenwein, Julia A.,
Ziemssen, Tjalf and
Linker, Ralf A.
(2019)
Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis.
Therapeutic Advances in Neurological Disorders 12, p. 175628641989207.
Fulltext not available.
This list was generated on Wed Dec 4 07:01:20 2024 CET.